Johnson & Johnson says single-dose COVID-19 vaccine will be a “game-changer”

Johnson & Johnson has released the results of its phase three COVID-19 vaccine trial and plans to seek emergency use authorization by the Food and Drug Administration.
Results demonstrated 85% p…
Read More

CBS News